Related Experiment Video
Updated: Jun 24, 2026

Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX
Published on: June 27, 2017
Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli
B A Pfeifer1, S J Admiraal, H Gramajo
1Department of Chemical Engineering, Stanford University, Stanford, CA 94305-5025, USA.
Abstract:
The macrocyclic core of the antibiotic erythromycin, 6-deoxyerythronolide B (6dEB), is a complex natural product synthesized by the soil bacterium Saccharopolyspora erythraea through the action of a multifunctional polyketide synthase (PKS). The engineering potential of modular PKSs is hampered by the limited capabilities for molecular biological manipulation of organisms (principally actinomycetes) in which complex polyketides have thus far been produced. To address this problem, a derivative of Escherichia coli has been genetically engineered. The resulting cellular catalyst converts exogenous propionate into 6dEB with a specific productivity that compares well with a high-producing mutant of S. erythraea that has been incrementally enhanced over decades for the industrial production of erythromycin.
Related Concept Videos
Amino Acid Catabolism
Biosynthesis in Bacteria
Bioreactor Controls-III
Production of Antibiotics
Production of Pharmaceuticals
Microbiota Modulation by Antibiotics

